News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,200 Results
Type
Article (14627)
Company Profile (282)
Press Release (254291)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79809)
Career Advice (155)
Deals (13257)
Drug Delivery (35)
Drug Development (50932)
Employer Resources (31)
FDA (5773)
Job Trends (5156)
News (145170)
Policy (10136)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (949)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21806)
ALS (65)
Alzheimer's disease (844)
Antibody-drug conjugate (ADC) (90)
Approvals (5793)
Artificial intelligence (120)
Autoimmune disease (17)
Automation (5)
Bankruptcy (105)
Best Places to Work (4585)
BIOSECURE Act (5)
Biosimilars (42)
Biotechnology (232)
Bladder cancer (47)
Brain cancer (21)
Breast cancer (147)
Cancer (1376)
Cardiovascular disease (117)
Career advice (134)
Career pathing (2)
CAR-T (111)
Cell therapy (316)
Cervical cancer (8)
Clinical research (41310)
Collaboration (519)
Compensation (254)
Complete response letters (13)
COVID-19 (1107)
CRISPR (39)
C-suite (154)
Cystic fibrosis (76)
Data (1437)
Denatured (11)
Depression (29)
Diabetes (131)
Diagnostics (1311)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (84)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29797)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48529)
Executive appointments (440)
FDA (6438)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (485)
Gene editing (95)
Generative AI (11)
Gene therapy (250)
GLP-1 (364)
Government (1106)
Grass and pollen (2)
Guidances (19)
Healthcare (6654)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (89)
Indications (18)
Infectious disease (1174)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (62)
Interviews (17)
IPO (7278)
IRA (11)
Job creations (862)
Job search strategy (128)
Kidney cancer (6)
Labor market (5)
Layoffs (208)
Leadership (3)
Legal (1408)
Liver cancer (31)
Lung cancer (195)
Lymphoma (90)
Machine learning (2)
Management (7)
Manufacturing (126)
MASH (50)
Medical device (2600)
Medtech (2601)
Mergers & acquisitions (6298)
Metabolic disorders (377)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (23)
Neuroscience (1240)
NextGen: Class of 2025 (2033)
Non-profit (864)
Northern California (1629)
Now hiring (22)
Obesity (191)
Opinion (102)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (53)
Parkinson's disease (121)
Partnered (8)
Patents (129)
Patient recruitment (69)
Peanut (35)
People (25645)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14646)
Phase II (19225)
Phase III (12131)
Pipeline (781)
Policy (43)
Postmarket research (854)
Preclinical (6122)
Press Release (33)
Prostate cancer (57)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (288)
Real estate (1423)
Recruiting (12)
Regulatory (8663)
Reports (15)
Research institute (958)
Resumes & cover letters (18)
Rett syndrome (4)
RNA editing (4)
RSV (13)
Schizophrenia (57)
Series A (95)
Series B (60)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1437)
Special edition (11)
Spinal muscular atrophy (118)
Sponsored (11)
Startups (1981)
State (1)
Stomach cancer (5)
Supply chain (21)
Tariffs (5)
The Weekly (36)
United States (12733)
Vaccines (234)
Venture capitalists (30)
Weight loss (108)
Women's health (15)
Worklife (2)
Date
Last 7 days (259)
Last 30 days (1295)
Last 365 days (19655)
2025 (5514)
2024 (20692)
2023 (22553)
2022 (26988)
2021 (27994)
2020 (23534)
2019 (16348)
2018 (11824)
2017 (13847)
2016 (11929)
2015 (14454)
2014 (10469)
2013 (7557)
2012 (7588)
2011 (7673)
2010 (7465)
Location
Africa (149)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17347)
Australia (2946)
California (3702)
Canada (1102)
China (333)
Colorado (142)
Connecticut (147)
Delaware (93)
Europe (37539)
Florida (444)
Georgia (120)
Idaho (16)
Illinois (221)
India (10)
Indiana (90)
Iowa (1)
Japan (74)
Kansas (61)
Kentucky (6)
Louisiana (3)
Maine (11)
Maryland (461)
Massachusetts (2923)
Michigan (72)
Minnesota (142)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (18)
New Hampshire (14)
New Jersey (938)
New Mexico (12)
New York (999)
North Carolina (540)
North Dakota (4)
Northern California (1629)
Ohio (110)
Oklahoma (9)
Oregon (21)
Pennsylvania (706)
Puerto Rico (5)
Rhode Island (16)
South America (212)
South Carolina (4)
Southern California (1437)
Tennessee (26)
Texas (429)
Utah (50)
Virginia (75)
Washington D.C. (30)
Washington State (338)
Wisconsin (14)
269,200 Results for "encoded therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Encoded Cuts 29% of Workforce to Extend Cash Runway, Advance Pipeline
Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected to keep the biotech operational well into 2026.
February 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy for Dravet Syndrome, Recaps 2024 Corporate Achievements and Provides 2025 Outlook
February 13, 2025
·
5 min read
Press Releases
Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit
November 7, 2024
·
3 min read
Press Releases
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
March 14, 2025
·
8 min read
Biotech Bay
Encoded Therapeutics Announces UK CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
Encoded Therapeutics Inc. today announced the approval of its Clinical Trial Authorisation (CTA) application by the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) for the EXPEDITION Study of ETX101 as a potential treatment for children with SCN1A+ Dravet syndrome.
February 26, 2024
·
5 min read
Biotech Bay
Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT).
April 23, 2024
·
5 min read
Drug Development
Encoded Therapeutics Presents Preclinical Data Across its Gene Therapy Portfolio at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system disorders, highlights oral and poster presentations on the Company’s preclinical gene therapy programs and vector engineering platform at the 27th ASGCT Annual Meeting being held May 7 – 11, 2024 in Baltimore, MD.
May 7, 2024
·
5 min read
Biotech Beach
Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
Encoded Therapeutics Inc., a biotechnology company focused on developing genetic medicines for severe central nervous system (CNS) disorders, today outlined the global development strategy for its lead gene therapy candidate, ETX101, for the treatment of SCN1A+ Dravet syndrome.
February 6, 2024
·
7 min read
Press Releases
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks
July 17, 2024
·
3 min read
Business
Aegis Life Receives Investment to Continue Development of DNA-Encoded Therapeutic Antibodies Against Infectious Diseases Using the Fusogenix PLV Platform
Aegis Life receives a program-related investment of $4.45M from the Bill & Melinda Gates Foundation.
March 19, 2024
·
6 min read
1 of 26,920
Next
